89BIO, INC. - Annual Financials - Income Statement (SEC)
Updated on January 2, 2026.
Related Topics: SEC Topic List.
Data Source: SEC.
See details in table below.
You can see similar for other companies.
89BIO, INC. - Annual Income Statement
(In Thousands of USD, Except Per Share Amounts)
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Research and development | 345037 | 122230 | 80796 |
| General and administrative | 39619 | 28974 | 21453 |
| Total operating expenses | 384656 | 151204 | 102249 |
| Loss from operations | -384656 | -151204 | -102249 |
| Interest expense | 5290 | 4794 | 1922 |
| Interest income and other, net | 23559 | 17676 | 2164 |
| Net loss before income tax | -366387 | -138322 | -102007 |
| Income tax expense | 692 | 3867 | 19 |
| Net loss | -367079 | -142189 | -102026 |
| Unrealized gain (loss) on marketable securities | 364 | 547 | -299 |
| Foreign currency translation adjustments | 9 | -7 | 13 |
| Total other comprehensive income (loss) | 373 | 540 | -286 |
| Comprehensive loss | -366706 | -141649 | -102312 |
| Basic Earnings Per Share | -3.51 | -2 | -2.93 |
| Diluted Earnings Per Share | -3.51 | -2 | -2.93 |
| Basic Weighted Average Shares Outstanding | 104714.613 | 71172.87 | 34806.349 |
| Diluted Weighted Average Shares Outstanding | 104714.613 | 71172.87 | 34806.349 |